시장보고서
상품코드
1441166

동결건조 주사제 시장 규모, 점유율, 성장 분석, 약물별, 적응증별, 산업별 - 산업 예측(2023-2030년)

Global Lyophilized Injectable Drugs Market Size, Share, Growth Analysis, By Drug(Anti-infective, Anti-neoplastic), By Indication(Autoimmune diseases, Respiratory diseases) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동결건조 주사제 시장 규모는 2022년 30억 9,000만 달러로 평가되었습니다. 2023년 33억 9,000만 달러에서 2031년에는 54억 4,000만 달러에 달하고, 예측 기간(2024-2031년) 동안 6.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 동결건조 주사제 시장은 주사에 적합한 안정된 분말 형태의 제형을 만들기 위해 동결건조된 의약품을 제공합니다. 이 공정은 수분을 제거하여 의약품의 저장 수명을 연장하고 보관 및 운송을 용이하게 합니다. 이 시장은 오염 위험 감소와 약효 유지라는 장점으로 인해 크게 성장하고 있습니다. 동결건조 주사제는 감염, 종양, 자가면역질환 등 다양한 치료 분야에 적용되고 있습니다. 제조 공정에서 약액을 동결한 후 진공 하에서 승화시켜 건조 분말을 얻는다. 시장의 주요 촉진요인은 특히 생물학적 제제 및 분해하기 쉬운 복잡한 분자에 대한 보다 안정적인 제제에 대한 수요입니다. 의료 서비스 제공업체는 보존 기간이 길어지고 폐기물이 줄어들기 때문에 이러한 약물을 선호합니다. 또한, 동결건조 의약품은 응급 상황이나 자원이 부족하여 냉장 시설이 부족한 환경에서 이점을 제공합니다. 하지만 특수 장비의 필요성과 제조 비용의 상승과 같은 문제도 존재합니다. 동결건조된 약물을 재구성할 때 실수가 발생하면 약물의 효과와 환자의 안전에 영향을 미칠 수 있고, 적절한 교육이 필요하며, 시간과 자원을 낭비할 수 있습니다. 이러한 장애물에도 불구하고 동결건조 기술의 지속적인 발전, 새로운 치료 영역의 연구 확대, 약물의 안정성을 높이기 위한 노력으로 시장 성장은 지속될 것으로 예상됩니다.

목차

주요 요약

  • 시장 개요
  • Wheel of Fortune

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 동결건조 주사제 시장 : 약물별

  • 시장 개요
  • 항감염증
  • 항종양성
  • 항응고제
  • 호르몬
  • 항부정맥제
  • 기타

세계의 동결건조 주사제 시장 : 적응증별

  • 시장 개요
  • 자가면역질환
  • 호흡기질환
  • 위장질환
  • 종양
  • 심혈관질환
  • 감염증
  • 대사장애
  • 기타

세계의 동결건조 주사제 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Pfizer Inc.
  • Novartis AG
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Amgen Inc.
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Celgene Corporation
  • Novo Nordisk A/S
  • Vertex Pharmaceuticals Incorporated
  • Takeda Pharmaceutical Company Limited
LSH 24.04.11

Global Lyophilized Injectable Drugs Market size was valued at USD 3.09 Billion in 2022 and is poised to grow from USD 3.39 Billion in 2023 to USD 5.44 Billion by 2031, at a CAGR of 6.5% during the forecast period (2024-2031).

The global market for lyophilized injectable drugs offers pharmaceutical products that have undergone freeze-drying to create stable, powder-like formulations suitable for injection. This process extends the shelf life of medications by removing water content, facilitating convenient storage and transportation. The market has experienced significant growth due to its benefits in reducing contamination risk and preserving drug efficacy. Lyophilized injectable drugs find application across various therapeutic areas such as infectious diseases, oncology, autoimmune disorders, and more. The manufacturing process involves freezing the drug solution, followed by sublimation under vacuum to obtain a dry powder that can be reconstituted into liquid form using a suitable solvent prior to administration. A key driver for the market is the demand for more stable formulations, particularly for biologics and complex molecules prone to degradation. Healthcare providers favor these drugs due to their extended shelf life, reducing wastage. Additionally, lyophilized drugs offer advantages in emergency situations and environments lacking refrigeration due to limited resources. Nevertheless, challenges such as the need for specialized equipment and higher production costs exist. Errors in reconstituting lyophilized drugs can affect medication effectiveness and patient safety, necessitating proper training and potentially wasting time and resources. Despite these obstacles, ongoing advancements in lyophilization techniques, expanding research in new therapeutic areas, and efforts to enhance drug stability are expected to sustain market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lyophilized Injectable Drugs and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lyophilized Injectable Drugs Market Segmental Analysis

The global lyophilized injectable drugs market is segmented by Drug, Indication, Delivery, Packaging, Distribution Channel, and Region. Based on Drug the market is segmented as, Anti-infective, Anti-neoplastic, Anticoagulant, Hormones, Antiarrhythmic, Others. Based on Indication the market is segmented as, autoimmune diseases, respiratory diseases, gastrointestinal disorders, Oncology, Cardiovascular diseases, Infectious diseases, Metabolic disorders, others. Based on Delivery the market is segmented as, Prefilled diluent syringes, Multi-step devices. Based on Packaging the market is segmented as, Vials, Cartridges, and Prefilled devices. Based on Distribution Channel the market is segmented as, Hospital pharmacy, Retail pharmacy, and online pharmacy. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Lyophilized Injectable Drugs Market

The rising demand for lyophilized injectable drugs is driven by the growing use of peptides, biologics, and other complex molecules in therapies. These drugs often require stable formulations to preserve their efficacy, given their delicate nature.

The process of lyophilization extends the shelf life of therapeutic drugs by removing water content and improving drug stability. Healthcare providers and pharmaceutical manufacturers seeking products with extended storage periods are particularly drawn to this advantageous characteristic.

Restraints in the Global Lyophilized Injectable Drugs Market

The rising demand for lyophilized injectable drugs is driven by the growing use of peptides, biologics, and other complex molecules in therapies. These drugs often require stable formulations to preserve their efficacy, given their delicate nature.

The process of lyophilization extends the shelf life of therapeutic drugs by removing water content and improving drug stability. Healthcare providers and pharmaceutical manufacturers seeking products with extended storage periods are particularly drawn to this advantageous characteristic.

Market Trends of the Global Lyophilized Injectable Drugs Market

Increase in Biologics and Complex Molecules: The market witnessed a rise in the development and utilization of peptides, biologics, and other complex molecules across different therapeutic areas. Lyophilization plays a crucial role in preserving the stability of these fragile molecules, ensuring their efficacy upon reconstitution, a critical factor in the industry.

Innovations in Drug Delivery: Technological advancements have led to improvements in drug delivery systems for lyophilized injectables. This includes the development of user-friendly devices and reconstitution mechanisms, enhancing patient convenience.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Lyophilized Injectable Drugs Market by Drug

  • Market Overview
  • Anti-infective
  • Anti-neoplastic
  • Anticoagulant
  • Hormones
  • Antiarrhythmic
  • Others

Global Lyophilized Injectable Drugs Market by Indication

  • Market Overview
  • Autoimmune diseases
  • Respiratory diseases
  • Gastrointestinal disorders
  • Oncology
  • Cardiovascular diseases
  • Infectious diseases
  • Metabolic disorders
  • and Others

Global Lyophilized Injectable Drugs Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol Myers Squibb Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilead Sciences, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biogen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celgene Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vertex Pharmaceuticals Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제